Last updated: 19 February 2021 at 4:16pm EST

Joseph Ferra Net Worth



Joseph Ferra biography

Joseph J. Ferra Jr. serves as Chief Financial Officer of the Company. He has served as our chief financial officer since March 2018. Mr. Ferra joined us from JMP Securities LLC, where he served as Managing Director from March 2014 to March 2018 and Co-Head of Healthcare Investment Banking from March 2017 to March 2018. Previously, he was employed by UBS Investment Bank from September 2009 to March 2014 serving, most recently, as Executive Director of Global Healthcare Investment Banking. Mr. Ferra received a B.S. in chemistry with distinction from Purdue University and an M.B.A. from The Stephen M. Ross School of Business at the University of Michigan.

What is the salary of Joseph Ferra?

As the Chief Financial Officer of Syros Pharmaceuticals, the total compensation of Joseph Ferra at Syros Pharmaceuticals is $2,394,620. There are 1 executives at Syros Pharmaceuticals getting paid more, with Nancy Simonian having the highest compensation of $3,614,020.



How old is Joseph Ferra?

Joseph Ferra is 44, he's been the Chief Financial Officer of Syros Pharmaceuticals since 2018. There are 19 older and no younger executives at Syros Pharmaceuticals. The oldest executive at Syros Pharmaceuticals Inc. is Phillip Sharp, 75, who is the Independent Director.

What's Joseph Ferra's mailing address?

Joseph's mailing address filed with the SEC is C/O SYROS PHARMACEUTICALS, INC., 35 CAMBRIDGEPARK DRIVE, CAMBRIDGE, MA, 02140.

Insiders trading at Syros Pharmaceuticals

Over the last 8 years, insiders at Syros Pharmaceuticals have traded over $8,259,551 worth of Syros Pharmaceuticals stock and bought 5,052,185 units worth $51,830,966 . The most active insiders traders include Group, Llc Green Jeremy Red..., Srinivas Akkaraju, and Stephane Bancel. On average, Syros Pharmaceuticals executives and independent directors trade stock every 38 days with the average trade being worth of $135,148. The most recent stock trade was executed by Richard A Young on 28 June 2024, trading 34,837 units of SYRS stock currently worth $178,365.



What does Syros Pharmaceuticals do?

syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical r&d. central to the syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of syros' senior leadership. while this scientific approach has applications in many therapeutic areas, syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.



What does Syros Pharmaceuticals's logo look like?

Syros Pharmaceuticals Inc. logo

Syros Pharmaceuticals executives and stock owners

Syros Pharmaceuticals executives and other stock owners filed with the SEC include: